Meeting Banner
Abstract #1765

Non-Invasive Imaging and Quantitative Readout of HCC Progression and Metastatic Development Using MRI

Lingyun Hu1, Ashley Aronow2, Lakshmi Raj2, Erica C. Henning1

1Global Imaging Group, Novartis Institutes for Biomedical Research (NIBR), Cambridge, MA, United States; 2Biologics Center, Novartis Institutes for Biomedical Research (NIBR), Cambridge, MA, United States

In this study, we employed combined MDEFT/RARE for non-invasive, longitudinal monitoring of HCC progression with high sensitivity and reliability. We were able to diagnose and quantify primary HCC tumor volume and secondary liver metastasis without contrast agent and without respiratory triggering. We achieved higher CNR than previous reports employing Gd-DTPA or Gd-EOB-DTPA, with a detection limit of 1mm diameter HCC versus 2mm reported. With easy setup and no contrast agent or respiratory triggering required, MDEFT/RARE provides a powerful alternative for accurate quantification of HCC, with relatively high throughput, improved study power, and reduction in animal use.

Keywords

accurate achieved acquisition adjacent agent allows alternative anatomical animal animals applied arrow beige biologics biomedical body bottom bottoms cancer carcinoma cause cavity cell chemotherapy chest clear clinic combined common comparable concomitant confidential contrast coronal coverage currently deaths definition delivered detection development diagnose done driven easy efficacy employing enhancement expression extended female field form global greater healthy henning identification identifying implantation improved in vivo include indicated institutes instruments intestine intestines invasive knockdown limit liver longitudinal maintained margins matrix median metastasis metastatic mice minimal monitor monitoring needed noise novel ongoing oxygen placebo positive power powerful primary progression propose protocol proximity quantification quantify quantitative randomization randomized rapid rare readout reduction relatively reliability reported reports representative required respiratory science secondary segmented sensitivity serum serving setup slice slices software starting stomach summary surgery system target temperature toxicity transform translation transplant treatment treatments triggering tumor tumors types underway urgently verification verify versatility versus view volume volumes weekly weeks worldwide